Janux Therapeutics Inc (JANX)

Stock-Based Compensation

$9.06M

Quarterly · Period ending: · USD

JANX logo

JANX Stock-Based Compensation

Latest reported$9.06M
JANX Quarterly Stock-Based Comp ($2.00K → $9.06M)
High-resolution chart · PNG

JANX stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Janux Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
9,062,000
9,269,000
9,515,000
9,044,000
10,960,000
10,702,000
6,251,000
15,387,000
5,757,000
5,625,000
4,483,000
4,548,000
5,501,000
5,473,000
4,205,000
4,596,000
4,444,000
3,958,000
2,944,000
2,566,000
1,277,000
123,000
40,000
28,000
2,000
2,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.